Poliovirus Receptor Antikörper (AA 314-342)
-
- Target Alle Poliovirus Receptor (PVR) Antikörper anzeigen
- Poliovirus Receptor (PVR)
-
Bindungsspezifität
- AA 314-342
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Poliovirus Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- This PVR antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 314-342 amino acids from the C-terminal region of human PVR.
- Aufreinigung
- Protein A purified
- Top Product
- Discover our top product PVR Primärantikörper
-
-
- Applikationshinweise
- Approved: ELISA, IHC, IHC-P (1:100), WB (1:1000)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, 0.09 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
- Haltbarkeit
- 6 months
-
- Target
- Poliovirus Receptor (PVR)
- Andere Bezeichnung
- PVR / CD155 (PVR Produkte)
- Synonyme
- PVR antikoerper, CD155 antikoerper, HVED antikoerper, NECL5 antikoerper, Necl-5 antikoerper, PVS antikoerper, TAGE4 antikoerper, 3830421F03Rik antikoerper, D7Ertd458e antikoerper, Taa1 antikoerper, Tage4 antikoerper, mE4 antikoerper, necl-5 antikoerper, poliovirus receptor antikoerper, PVR antikoerper, Pvr antikoerper
- Hintergrund
-
Name/Gene ID: PVR
Synonyms: PVR, CD155, Hpvr, HVED, Nectin-like 5, Nectin-like protein 5, Poliovirus receptors beta, Poliovirus receptor, PVS, Necl-5, CD155 antigen, NECL5, TAGE4 - Gen-ID
- 5817
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interaktom
-